DailyDoctor Archive Specialties Get app
All top clinical updates briefings

The edition · Top Clinical Updates

Tuberculosis and lung nodules back to first principles, and immunotherapy moves into resectable gastric cancer

Two clinical reviews worth an hour of anyone's time, a pig kidney that kept a patient off dialysis for 271 days, and a phase 3 survival result that changes the perioperative standard.

The edition in brief

Two practical reviews lead: tuberculosis, still the world's leading infectious cause of death and now rising in high-income settings, where confirmation needs smear, nucleic acid amplification and culture together and treatment runs four to nine months under drug sensitivity testing; and pulmonary nodules, where management turns on solid versus subsolid, on comparison with old imaging, and on the two-year stability rule that applies to solid nodules but not subsolid ones. In 4,804 adults with Down syndrome across seven cohorts, epilepsy rose steeply once Alzheimer's disease became symptomatic, from a cumulative 9.5% at diagnosis to 56.9% nine years later, and late-onset myoclonic epilepsy carried a doubled mortality (hazard ratio 2.10, 95% CI 1.57 to 2.82) with faster cognitive decline; interictal EEG was of little diagnostic help. A first-in-human report describes a gene-edited porcine kidney that gave one patient 271 days free of dialysis before thrombotic microangiopathy forced nephrectomy, with no porcine pathogen transmission, no change in anti-HLA antibodies, and a successful human transplant 82 days later. The practice-changer is MATTERHORN: in 948 patients with resectable gastric or gastro-oesophageal junction adenocarcinoma, adding perioperative durvalumab to FLOT chemotherapy improved overall survival, hazard ratio 0.78 (95% CI 0.63 to 0.96), establishing a new standard treatment option and a new reason to discuss oncology referral before surgery rather than after it.

In this edition
01Clinical update

Tuberculosis, reviewed for clinicians who do not see it every week

Send all three microbiological tests, isolate on suspicion rather than confirmation, and take responsibility for contact screening rather than delegating it onwards.

2 min · Annals of internal medicineRead →
02Clinical update

The pulmonary nodule on someone else's scan

Before acting on any incidental nodule, get the old scans and establish whether it is solid or subsolid — those two steps determine everything that follows.

2 min · The New England journal of medicineRead →
03Research

Epilepsy in Down syndrome rises steeply once dementia becomes symptomatic

In an adult with Down syndrome and symptomatic dementia, ask about myoclonic jerks at every review and diagnose clinically — a normal EEG does not settle it.

2 min · Lancet (London, England)Read →
04Research

271 days off dialysis on a pig kidney, then a human transplant that worked

Nothing to act on — but if a patient asks about pig kidneys, the honest answer is now 271 days of function in one person, ended by a rejection mechanism that is not yet understood.

2 min · Lancet (London, England)Read →
05Pearl

The old scan is the test you already have

Before investigating anything described as new, spend two minutes establishing whether it is actually new.

1 minRead →
06
Practice changer

Perioperative durvalumab improves survival in resectable gastric cancer

A patient with newly diagnosed resectable gastric or gastro-oesophageal junction adenocarcinoma should reach medical oncology before they reach a surgical date.

2 min · Lancet (London, England)Read →
Primary outcome
Overall survival in the intention-to-treat population (key secondary endpoint; event-free survival was the primary)
Effect
Hazard ratio 0.78 (95% CI 0.63-0.96; p=0.021 against a threshold of p<0.0499); possibly treatment-related deaths 6/475 with durvalumab vs 2/469 with placebo

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for top clinical updates, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free